Fang M - Search Results

1

Purification of a non-tagged recombinant BCG heat shock protein 65-Her2 peptide fusion protein from Escherichia coli.

Feng Y, Wan M, Xiang Z, Wei H, Hu X, Wang Y, Dai L, Fang M, Zhang X, Yu Y, Wang L. Feng Y, et al. Among authors: fang m. Protein Expr Purif. 2007 Jun;53(2):390-5. doi: 10.1016/j.pep.2006.12.015. Epub 2006 Dec 24. Protein Expr Purif. 2007. PMID: 17275328

2

Purification of clinical-grade recombinant HSP65-MUCI fusion protein.

Cao Z, Feng Y, Wei H, Fang M, Hu X, Yu Y, Wang L, Wan M. Cao Z, et al. Among authors: fang m. Biotechnol Appl Biochem. 2010 Sep;57(1):9-15. doi: 10.1042/BA20090358. Biotechnol Appl Biochem. 2010. PMID: 20704567

3

An oligodeoxynucleotide capable of lessening acute lung inflammatory injury in mice infected by influenza virus.

Fang M, Wan M, Guo S, Sun R, Yang M, Zhao T, Yan Y, Zhang Y, Huang W, Wu X, Yu Y, Wang L, Hua S. Fang M, et al. Biochem Biophys Res Commun. 2011 Nov 18;415(2):342-7. doi: 10.1016/j.bbrc.2011.10.062. Epub 2011 Oct 18. Biochem Biophys Res Commun. 2011. PMID: 22033400

4

Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.

Fang M, Li J, Wang H, Yang M, Zhang Y, Zhou L, Wei H, Yang G, Yu Y, Wei X, Yu Y, Wang L, Wan M. Fang M, et al. Biotechnol Lett. 2012 May;34(5):839-47. doi: 10.1007/s10529-012-0856-0. Biotechnol Lett. 2012. PMID: 22286179

5

MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice.

Yang M, Yan Y, Fang M, Wan M, Wu X, Zhang X, Zhao T, Wei H, Song D, Wang L, Yu Y. Yang M, et al. Among authors: fang m. Int Immunopharmacol. 2012 Aug;13(4):408-16. doi: 10.1016/j.intimp.2012.05.003. Epub 2012 May 14. Int Immunopharmacol. 2012. PMID: 22595192 Free PMC article.

6

Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.

Zhao T, Wu X, Song D, Fang M, Guo S, Zhang P, Wang L, Wang L, Yu Y. Zhao T, et al. Among authors: fang m. Int Immunopharmacol. 2012 Dec;14(4):665-73. doi: 10.1016/j.intimp.2012.09.018. Epub 2012 Oct 9. Int Immunopharmacol. 2012. PMID: 23063973

7

Influence of hydrophilic amino acids and GC-content on expression of recombinant proteins used in vaccines against foot-and-mouth disease virus in Escherichia coli.

Wei H, Fang M, Wan M, Wang H, Zhang P, Hu X, Wu X, Yang M, Zhang Y, Zhou L, Jiao C, Hua L, Diao W, Xiao Y, Yu Y, Wang L. Wei H, et al. Among authors: fang m. Biotechnol Lett. 2014 Apr;36(4):723-9. doi: 10.1007/s10529-013-1421-1. Epub 2013 Dec 29. Biotechnol Lett. 2014. PMID: 24375229

8

miRNA profiling reveals a potential role of milk stasis in breast carcinogenesis.

Gu YQ, Gong G, Xu ZL, Wang LY, Fang ML, Zhou H, Xing H, Wang KR, Sun L. Gu YQ, et al. Int J Mol Med. 2014 May;33(5):1243-9. doi: 10.3892/ijmm.2014.1677. Epub 2014 Feb 27. Int J Mol Med. 2014. PMID: 24584717

9

Single immunization with a recombinant multiple-epitope protein induced protection against FMDV type Asia 1 in cattle.

Fang M, Wang H, Tang T, Zhao P, Du J, Guo S, Wei H, Xu H, Wan M, Wei X, Yu Y, Wang L. Fang M, et al. Int Immunopharmacol. 2015 Oct;28(2):960-6. doi: 10.1016/j.intimp.2015.08.017. Epub 2015 Sep 10. Int Immunopharmacol. 2015. PMID: 26365702

10

The therapeutic potency of HSP65-GTL in GL261 glioma-bearing mice.

Yan Y, Fang M, Xuan W, Wu X, Meng X, Wang L, Yu Y. Yan Y, et al. Among authors: fang m. J Immunother. 2015 Nov-Dec;38(9):341-9. doi: 10.1097/CJI.0000000000000094. J Immunother. 2015. PMID: 26448578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,318 results

Search Page

Filters